Sign inGet started

AH Equity Partners Bio II, L.L.C.

Insider CIK 1725722 · NAUT 10% owner · EQRX 10% owner · SCTX 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SCTX Scribe Therapeutics, Inc. C Conversion deriv2026-07-272026-07-2912,150,003— $00SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion deriv2026-07-272026-07-294,131,344— $00SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion2026-07-272026-07-292,051,742— $02,051,742SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion2026-07-272026-07-29697,650— $0697,650SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-272026-07-29333,333$15.00 $5.00M2,385,075SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion deriv2026-07-272026-07-294,131,344— $00SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion deriv2026-07-272026-07-2912,150,003— $00SEC↗
SCTX Scribe Therapeutics, Inc. P Buy2026-07-272026-07-29333,333$15.00 $5.00M2,385,075SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion2026-07-272026-07-29697,650— —697,650SEC↗
SCTX Scribe Therapeutics, Inc. C Conversion2026-07-272026-07-292,051,742— —2,051,742SEC↗
NAUT Nautilus Biotechnology, In S Sale2026-06-022026-06-04384,026$2.35 $902.5K971,885SEC↗
NAUT Nautilus Biotechnology, In S Sale2026-06-022026-06-044,615,974$2.35 $10.85M11,682,032SEC↗
EQRX EQRx, Inc. U Tender deriv2023-11-092023-11-091,574,510— $00SEC↗
EQRX EQRx, Inc. U Tender deriv2023-11-092023-11-092,642,897— $00SEC↗
EQRX EQRx, Inc. U Tender deriv2023-11-092023-11-092,401,418— $00SEC↗
EQRX EQRx, Inc. U Tender2023-11-092023-11-0919,192,015— $00SEC↗
EQRX EQRx, Inc. U Tender2023-11-092023-11-0912,264— $00SEC↗
EQRX EQRx, Inc. U Tender2023-11-092023-11-0917,438,465— $00SEC↗
EQRX EQRx, Inc. U Tender2023-11-092023-11-0911,433,677— $00SEC↗
EQRX EQRx, Inc. U Tender2023-11-092023-11-095,000,000— $00SEC↗
EQRX EQRx, Inc. A Award deriv2023-01-012023-01-048,246— $01,574,510SEC↗
EQRX EQRx, Inc. A Award deriv2023-01-012023-01-0412,577— $02,401,418SEC↗
EQRX EQRx, Inc. A Award deriv2023-01-012023-01-0413,842— $02,642,897SEC↗